Last reviewed · How we verify

NCT07109804

Cuneiform Nucleus (CnF) Deep Brain Stimulation for Gait Facilitation Following Spinal Cord Injury

Recruiting now NA Last updated 6 April 2026
What this trial tests

NA trial testing Deep Brain Stimulation (DBS) in Spinal Cord Injuries in 6 participants. Currently enrolling.

Timeline
30 April 2026
Primary endpoint
31 December 2026
31 December 2026

Quick facts

Lead sponsorUniversity of Miami
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposedevice feasibility
Enrollment6
Start date30 April 2026
Primary completion31 December 2026
Estimated completion31 December 2026
Sites2 locations across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of Miami

Who can join

Adults 22 to 70, any sex, with Spinal Cord Injuries. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a study about deep brain stimulation (DBS) as an investigational treatment for walking impairment following spinal cord injury (SCI). The purpose of this study is to assess the feasibility and inform on the safety, and efficacy of CnF DBS to improve gait in SCI patients with incomplete injury who cannot effectively walk overground

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Stereotactic rodent-to-human approximation of the mesencephalic cuneiform nucleus to guide deep brain stimulation.
    Hofer AS, Scheuber MI, Sartori AM, Skorup I, et al · · 2026 · PMID 41786287 · DOI 10.1016/j.brs.2026.103066

Verify or expand the search:

Other trials of Deep Brain Stimulation (DBS)

Trials testing the same drug.

Other recruiting trials for Spinal Cord Injuries

Currently open trials in the same condition.

Other University of Miami trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07109804.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing